These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35945203)

  • 1. Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance.
    Vasseur S; Guillaumond F
    Oncogenesis; 2022 Aug; 11(1):46. PubMed ID: 35945203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids as mediators of cancer progression and metastasis.
    Vogel FCE; Chaves-Filho AB; Schulze A
    Nat Cancer; 2024 Jan; 5(1):16-29. PubMed ID: 38273023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid metabolism in tumor immunology and immunotherapy.
    Duong LK; Corbali HI; Riad TS; Ganjoo S; Nanez S; Voss T; Barsomium H; Welsh J; Cortez MA
    Front Oncol; 2023; 13():1187279. PubMed ID: 37205182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Dietary Polyunsaturated Fatty Acid Intake on Potential Lipid Metabolite Diagnostic Markers in Renal Cell Carcinoma: A Case-Control Study.
    Kim YH; Chung JS; Lee HH; Park JH; Kim MK
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins as anti-tumor agents: A paradigm for repurposed drugs.
    Tripathi S; Gupta E; Galande S
    Cancer Rep (Hoboken); 2024 May; 7(5):e2078. PubMed ID: 38711272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportion.
    Reitsam NG; Grosser B; Enke JS; Mueller W; Westwood A; West NP; Quirke P; Märkl B; Grabsch HI
    Transl Oncol; 2024 Jun; 44():101913. PubMed ID: 38593584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells.
    Lee J; Jang S; Im J; Han Y; Kim S; Jo H; Wang W; Cho U; Kim SI; Seol A; Kim B; Song YS
    J Ovarian Res; 2024 Apr; 17(1):73. PubMed ID: 38566208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.
    Yang Y; Li H; Liu K; Zou L; Xiang S; Geng Y; Li X; Qiu S; Yang J; Cui X; Li L; Li Y; Li W; Yan S; Liu L; Wu X; Liu F; Wu W; Chen S; Liu Y
    J Transl Med; 2024 Mar; 22(1):299. PubMed ID: 38519939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons.
    Modica R; La Salvia A; Liccardi A; Cozzolino A; Di Sarno A; Russo F; Colao A; Faggiano A;
    Endocrine; 2024 Mar; ():. PubMed ID: 38509261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intergenomic signatures of coevolution between Tasmanian devils and an infectious cancer.
    Gallinson DG; Kozakiewicz CP; Rautsaw RM; Beer MA; Ruiz-Aravena M; Comte S; Hamilton DG; Kerlin DH; McCallum HI; Hamede R; Jones ME; Storfer A; McMinds R; Margres MJ
    Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2307780121. PubMed ID: 38466855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocyte‑rich microenvironment promotes chemoresistance via upregulation of peroxisome proliferator‑activated receptor gamma/ABCG2 in epithelial ovarian cancer.
    Chen S; Liu Z; Wu H; Wang B; Ouyang Y; Liu J; Zheng X; Zhang H; Li X; Feng X; Li Y; Shen Y; Zhang H; Xiao B; Yu C; Deng W
    Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38426604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial heterogeneity of peri-tumoural lipid composition in postmenopausal patients with oestrogen receptor positive breast cancer.
    Cheung SM; Chan KS; Zhou W; Husain E; Gagliardi T; Masannat Y; He J
    Sci Rep; 2024 Feb; 14(1):4699. PubMed ID: 38409583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer.
    Enke JS; Groß M; Grosser B; Sipos E; Steinestel J; Löhr P; Waidhauser J; Lapa C; Märkl B; Reitsam NG
    BMC Cancer; 2024 Jan; 24(1):65. PubMed ID: 38216952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.
    Menendez JA; Cuyàs E; Encinar JA; Vander Steen T; Verdura S; Llop-Hernández À; López J; Serrano-Hervás E; Osuna S; Martin-Castillo B; Lupu R
    Mol Oncol; 2024 Mar; 18(3):479-516. PubMed ID: 38158755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Oxysterols in Age-Related Disorders and Strategies to Alleviate Adverse Effects.
    Ghosh S; Ghzaiel I; Vejux A; Meaney S; Nag S; Lizard G; Tripathi G; Naez F; Paul S
    Adv Exp Med Biol; 2024; 1440():163-191. PubMed ID: 38036880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the enigma of tumor-associated macrophages: challenges, innovations, and the path to therapeutic breakthroughs.
    Shao S; Miao H; Ma W
    Front Immunol; 2023; 14():1295684. PubMed ID: 38035068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients.
    Arévalo C; Rojas L; Santamaria M; Molina L; Arbeláez L; Sánchez P; Ballesteros-Ramírez R; Arevalo-Zambrano M; Quijano S; Cala MP; Fiorentino S
    Front Mol Biosci; 2023; 10():1235160. PubMed ID: 38028534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling Disrupted Lipid Metabolism in Benign Prostate Hyperplasia, Prostate Cancer, and Metastatic Patients: Insights from a Colombian Nested Case-Control Study.
    Pardo-Rodriguez D; Santamaría-Torres M; Salinas A; Jiménez-Charris E; Mosquera M; Cala MP; García-Perdomo HA
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biomarker SARIFA in colorectal cancer: highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology.
    Reitsam NG; Grozdanov V; Löffler CML; Muti HS; Grosser B; Kather JN; Märkl B
    Cancer Gene Ther; 2024 Feb; 31(2):207-216. PubMed ID: 37990064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Disturbances in Breast Cancer Patients during Chemotherapy.
    Alimperti A; Alikari V; Tsironi M; Rojas Gil AP; Papageorgiou D; Kolovos P; Panagiotou A; Panoutsopoulos GI; Lavdaniti M; Zyga S
    Nurs Rep; 2023 Oct; 13(4):1500-1510. PubMed ID: 37987405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.